Novo Nordisk | Der Umsatz

Sales Veränderung Datum
ANI Pharmaceuticals USD 137.4M 5.75M 2024-03
Aurora Cannabis CAD 64.42M 1M 2023-12
Bausch Health Companies USD 2.15B 258M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Canopy Growth CAD 72.79M 5.72M 2024-03
Catalent USD 1.12B 96M 2024-03
Corcept Therapeutics USD 146.81M 11.4M 2024-03
Drreddys Laboratories INR 72.15B 3.35B 2023-12
Eli Lilly USD 8.77B 583.4M 2024-03
GlaxoSmithKline GBP 7.36B 692M 2024-03
Merck USD 15.8B 1.17B 2024-03
Novartis USD 11.83B 54M 2024-03
Novo Nordisk DKK 65.35B 514M 2024-03
Pacira USD 167.12M 14.12M 2024-03
Perrigo USD 1.1B 56.9M 2024-03
Prestige Brands USD 276.99M 5.75M 2024-03
Sanofi EUR 10.46B 455M 2024-03
Supernus Pharmaceuticals USD 143.6M 20.71M 2024-03
Zoetis USD 2.2B 13M 2024-03



Novo Nordisk Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.